See more : Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) Income Statement Analysis – Financial Results
Complete financial analysis of DataVan International Corporation (3521.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DataVan International Corporation, a leading company in the Computer Hardware industry within the Technology sector.
- ZJBC Information Technology Co., Ltd (000889.SZ) Income Statement Analysis – Financial Results
- Daiwa House Industry Co., Ltd. (DWAHF) Income Statement Analysis – Financial Results
- SRG Global Limited (SRG.AX) Income Statement Analysis – Financial Results
- Akastor ASA (0IPT.L) Income Statement Analysis – Financial Results
- Ardent Leisure Group Limited (ALG.AX) Income Statement Analysis – Financial Results
DataVan International Corporation (3521.TWO)
About DataVan International Corporation
DataVan International Corporation provides POS terminals worldwide. The company engages in the research and development, design, manufacturing, and sale of software and hardware of the terminal sales system, computer information equipment, and peripheral equipment parts; import and export of accessories and supplies; construction of public housing; selling and leasing of residential buildings; and invests in public construction, as well as real estate trading. It offers desktop POS; smart retail management and service systems; mobile payment terminal; box PCs; kiosks self-service systems; panel PCs; contactless access control solutions; digital signage; and POS peripherals and extension kits. The company was formally known as Anjie International Co., Ltd. and changed its name to DataVan International Corporation in November 2003. DataVan International Corporation was founded in 1986 and is headquartered in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 276.12M | 255.45M | 363.92M | 317.17M | 1.43B |
| Cost of Revenue | 244.73M | 219.83M | 319.19M | 265.04M | 1.18B |
| Gross Profit | 31.39M | 35.62M | 44.73M | 52.13M | 256.59M |
| Gross Profit Ratio | 11.37% | 13.94% | 12.29% | 16.44% | 17.92% |
| Research & Development | 19.69M | 15.15M | 14.99M | 14.57M | 24.03M |
| General & Administrative | 47.67M | 36.64M | 33.14M | 25.56M | 27.08M |
| Selling & Marketing | 77.75M | 48.04M | 51.89M | 57.85M | 80.09M |
| SG&A | 125.43M | 84.68M | 85.03M | 83.41M | 108.73M |
| Other Expenses | 0.00 | -4.39M | -3.51M | 13.04M | 0.00 |
| Operating Expenses | 149.22M | 99.84M | 100.02M | 97.99M | 132.76M |
| Cost & Expenses | 393.94M | 319.67M | 419.21M | 363.03M | 1.31B |
| Interest Income | 1.44M | 261.00K | 121.00K | 1.20M | 144.00K |
| Interest Expense | 14.38M | 12.92M | 10.51M | 9.71M | 9.08M |
| Depreciation & Amortization | 28.23M | 20.96M | 18.98M | 18.77M | 13.57M |
| EBITDA | -145.95M | -46.45M | -36.11M | -13.32M | 137.40M |
| EBITDA Ratio | -52.86% | -16.87% | -10.91% | -4.05% | 9.60% |
| Operating Income | -113.72M | -64.07M | -58.68M | -31.63M | 123.83M |
| Operating Income Ratio | -41.19% | -25.08% | -16.13% | -9.97% | 8.65% |
| Total Other Income/Expenses | -74.83M | -16.26M | -10.31M | 4.06M | -2.54M |
| Income Before Tax | -188.55M | -80.33M | -65.61M | -41.80M | 121.29M |
| Income Before Tax Ratio | -68.29% | -31.45% | -18.03% | -13.18% | 8.47% |
| Income Tax Expense | 8.14M | 5.60M | 15.18M | 0.00 | 0.00 |
| Net Income | -192.01M | -85.77M | -79.32M | -41.80M | 121.29M |
| Net Income Ratio | -69.54% | -33.57% | -21.79% | -13.18% | 8.47% |
| EPS | -2.76 | -1.70 | -1.68 | -0.89 | 2.60 |
| EPS Diluted | -2.76 | -1.70 | -1.68 | -0.89 | 2.59 |
| Weighted Avg Shares Out | 69.46M | 50.56M | 47.21M | 46.73M | 46.83M |
| Weighted Avg Shares Out (Dil) | 69.46M | 50.56M | 47.21M | 46.73M | 46.77M |
Source: https://incomestatements.info
Category: Stock Reports